-
-
-
-
-
-
-
Stifel on Celcuity Inc (CELC) Amid 20% Selloff: 'We remain confident in PIK3CA-WT regulatory prospects'
-
-
-
-
-
-
-
Celcuity expands Phase 3 breast cancer trial to include new patient group
-
-
-
-
-
-
-
Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
15,439 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

